Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9651 USD | -5.38% | -18.90% | -31.06% |
May. 09 | Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating | MT |
May. 09 | Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating | MT |
Financials (USD)
Sales 2024 * | 73K | Sales 2025 * | 4.5M | Capitalization | 154M |
---|---|---|---|---|---|
Net income 2024 * | -164M | Net income 2025 * | -153M | EV / Sales 2024 * | 3,843 x |
Net Debt 2024 * | 126M | Net Debt 2025 * | 193M | EV / Sales 2025 * | 77.3 x |
P/E ratio 2024 * |
-0.94
x | P/E ratio 2025 * |
-1.35
x | Employees | 233 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.3% |
Latest transcript on Seres Therapeutics, Inc.
1 day | -5.38% | ||
1 week | -18.90% | ||
Current month | -2.57% | ||
1 month | +47.41% | ||
3 months | -8.95% | ||
6 months | -9.80% | ||
Current year | -31.06% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Shaff
CEO | Chief Executive Officer | 48 | 14-10-31 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 50 | 20-10-21 |
Chief Tech/Sci/R&D Officer | - | 15-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 78 | 15-03-31 |
Director/Board Member | 68 | 23-01-03 | |
Richard Kender
BRD | Director/Board Member | 68 | 14-10-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.03% | 234 M€ | +2.60% | - | |
0.02% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 0.9651 | -5.38% | 3,447,426 |
24-05-10 | 1.02 | -0.97% | 3,874,539 |
24-05-09 | 1.03 | +37.44% | 16,781,290 |
24-05-08 | 0.7494 | -32.49% | 15,045,030 |
24-05-07 | 1.11 | -6.72% | 6,829,813 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.06% | 154M | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |
- Stock Market
- Equities
- MCRB Stock